Droxidopa Capsule
Product Images NDC 59651-375

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 59651-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Droxidopa Fig1)

A line graph depicting the mean change in dizziness over eight weeks during a double-blind treatment phase. Two groups are compared: Droxidopa and placebo. The x-axis shows weeks from baseline to week 8, and the y-axis indicates mean change in dizziness. Droxidopa group shows a larger decrease in dizziness at week 1 maintained over time, while the placebo group shows a smaller decrease with less change. Error bars indicate variability and a significant difference (p<0.05) is noted at week 1.*

FDA Label Image

Figure2 (Droxidopa Fig2)

A bar graph comparing the percent of subjects reporting improvement in OHSA Question 1 between Placebo and Droxidopa groups. The x-axis represents improvement scores ranging from -8 (worse) to +8 (better), while the y-axis shows the percent of subjects in each category.*

FDA Label Image

Package Label.principal Display Panel- 100 mg (90 Capsules Bottle) (Droxidopa Fig3)

Label for Droxidopa Capsules 100 mg, containing 90 capsules. The label includes the National Drug Code (NDC) 59651-375-90 and is distributed by Aurobindo Pharma USA, Inc. The label instructs storage at 20º to 25ºC, includes a warning to keep out of reach of children, and advises not to use if the printed seal under the cap is broken or missing. The product is made in India.*

FDA Label Image

Package Label.principal Display Panel- 200 mg (90 Capsules Bottle) (Droxidopa Fig4)

Label for Droxidopa Capsules 200 mg oral capsules, distributed by Aurobindo Pharma USA, Inc. The package contains 90 capsules. Storage instructions specify 20° to 25°C in a light-resistant container. The label includes NDC 59651-376-90, warnings to keep out of reach of children, and manufacturing information indicating the product is made in India.*

FDA Label Image

Package Label.principal Display Panel- 300 mg (90 Capsules Bottle) (Droxidopa Fig5)

Label for Droxidopa Capsules 300 mg by Aurobindo Pharma Limited. The label states that each capsule contains 300 mg Droxidopa, includes storage instructions (20° to 25°C), and cautions to keep out of reach of children. The package contains 90 capsules with distribution details and a barcode on the right side.*

FDA Label Image

Chemical Structer (Droxidopa Str)

Chemical structure of Droxidopa showing its molecular arrangement including hydroxyl groups, an amine group, and a carboxylic acid group as part of the compound's chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.